ReP USP - Resultado da busca

Artigo de periodico
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2) (2023)
Melo, Adriana; Carvalho, Luciana Martins de; Ferriani, Virgínia Paes Leme ; Cavalcanti, Andre; Appenzeller, Simone; Oliveira, Valeria Rossato; Neto, Herberto Chong; Rosario, Nelson Augusto; Poswar, Fabiano de Oliveira; Kalil Filho, Jorge Elias
Source: Advances in rheumatology. Unidades: FM, FMRP
Subjects: ENZIMAS, AMÔNIA, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Adriana et al. A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2). Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53785. Acesso em: 05 nov. 2024.
APA
Melo, A., Carvalho, L. M. de, Ferriani, V. P. L., Cavalcanti, A., Appenzeller, S., Oliveira, V. R., et al. (2023). A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2). Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00303-5
NLM
Melo A, Carvalho LM de, Ferriani VPL, Cavalcanti A, Appenzeller S, Oliveira VR, Neto HC, Rosario NA, Poswar F de O, Kalil Filho JE. A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2) [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53785
Vancouver
Melo A, Carvalho LM de, Ferriani VPL, Cavalcanti A, Appenzeller S, Oliveira VR, Neto HC, Rosario NA, Poswar F de O, Kalil Filho JE. A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2) [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53785
Artigo de periodico
Identifying cost-saving opportunities for surgical care via multicenter time-driven activity-based costing (TDABC) analysis as exemplarily shown for cholecystectomy (2022)
Etges, Ana Paula Beck da Silva; Cruz, Luciane Nascimento; Schlatter, Rosane Paixão; Neyeloff, Jeruza; Ferranti, Eliziane; Kopittke, Luciane; Nunes, Altacilio Aparecido ; Santos, José Sebastião dos ; Ungari, Andrea Queiróz; Figueiredo Neto, José Albuquerque de; Nogueira, José Luiz; Assis, Renata Melo de; Moreira, Leila Beltrami; Polanczyk, Carisi Anne
Source: Journal of Hospital Management and Health Policy. Unidade: FMRP
Subjects: CIRURGIA, COLECISTECTOMIA, CUSTOS DOS CUIDADOS DE SAÚDE, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ETGES, Ana Paula Beck da Silva et al. Identifying cost-saving opportunities for surgical care via multicenter time-driven activity-based costing (TDABC) analysis as exemplarily shown for cholecystectomy. Journal of Hospital Management and Health Policy, v. 6, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.21037/jhmhp-21-34. Acesso em: 05 nov. 2024.
APA
Etges, A. P. B. da S., Cruz, L. N., Schlatter, R. P., Neyeloff, J., Ferranti, E., Kopittke, L., et al. (2022). Identifying cost-saving opportunities for surgical care via multicenter time-driven activity-based costing (TDABC) analysis as exemplarily shown for cholecystectomy. Journal of Hospital Management and Health Policy, 6, 1-11. doi:10.21037/jhmhp-21-34
NLM
Etges APB da S, Cruz LN, Schlatter RP, Neyeloff J, Ferranti E, Kopittke L, Nunes AA, Santos JS dos, Ungari AQ, Figueiredo Neto JA de, Nogueira JL, Assis RM de, Moreira LB, Polanczyk CA. Identifying cost-saving opportunities for surgical care via multicenter time-driven activity-based costing (TDABC) analysis as exemplarily shown for cholecystectomy [Internet]. Journal of Hospital Management and Health Policy. 2022 ; 6 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.21037/jhmhp-21-34
Vancouver
Etges APB da S, Cruz LN, Schlatter RP, Neyeloff J, Ferranti E, Kopittke L, Nunes AA, Santos JS dos, Ungari AQ, Figueiredo Neto JA de, Nogueira JL, Assis RM de, Moreira LB, Polanczyk CA. Identifying cost-saving opportunities for surgical care via multicenter time-driven activity-based costing (TDABC) analysis as exemplarily shown for cholecystectomy [Internet]. Journal of Hospital Management and Health Policy. 2022 ; 6 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.21037/jhmhp-21-34
Artigo de periodico
Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: across-sectional study (2021)
Goudouris, Ekaterini Simões ; Mariz, Fernanda Pinto ; Mendonça, Leonardo Oliveira; Aranda, Carolina Sanchez ; Guimarães, Rafaela Rolla; Kokron, Cristina Maria ; Barros, Myrthes Anna Maragna Toledo ; Anísio, Flávia; Alonso, Maria Luiza Oliva ; Marcelino, Fernanda Casares ; Valle, Solange Oliveira Rodrigues ; Dortas Junior, Sergio Duarte ; Barreto, Irma Douglas Paes ; Ferreira, Janáira Fernandes Severo ; Roxo Junior, Pérsio ; Silva, Almerinda Maria do Rego ; Campinhos, Fernanda Lugão ; Bonfim, Carmem; Loth, Gisele ; Fernandes, Juliana Folloni ; Garcia, Julia Lopes; Capelo, Albertina ; Takano, Olga Akiko ; Nadaf, Maria Isabel Valdomir ; Toledo, Eliana C.; Cunha, Luciana Araújo Oliveira ; Gesu, Regina Sumiko Watanabe Di ; Ferreira, Laire Schidlowski ; Fillipo, Priscila; Silva, Daniélli C. Bichuetti ; Soldateli, Gustavo ; Ferraroni, Natasha Rebouças ; Dantas, Ellen de Oliveira; Pestana, Simone ; Mansour, Eli ; Ulaf, Raisa Gusso ; Prando, Carolina ; Condino Neto, Antonio ; Grumach, Anete Sevciovi
Source: Journal of Clinical Immunology. Unidades: FM, FMRP, ICB
Subjects: IMUNOLOGIA, COVID-19, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, ESTUDOS TRANSVERSAIS, ESTUDOS MULTICÊNTRICOS, PACIENTES, MULHERES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOUDOURIS, Ekaterini Simões et al. Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: across-sectional study. Journal of Clinical Immunology, v. 41, n. 7, p. 1479-1489, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10875-021-01066-8. Acesso em: 05 nov. 2024.
APA
Goudouris, E. S., Mariz, F. P., Mendonça, L. O., Aranda, C. S., Guimarães, R. R., Kokron, C. M., et al. (2021). Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: across-sectional study. Journal of Clinical Immunology, 41( 7), 1479-1489. doi:10.1007/s10875-021-01066-8
NLM
Goudouris ES, Mariz FP, Mendonça LO, Aranda CS, Guimarães RR, Kokron CM, Barros MAMT, Anísio F, Alonso MLO, Marcelino FC, Valle SOR, Dortas Junior SD, Barreto IDP, Ferreira JFS, Roxo Junior P, Silva AM do R, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Gesu RSWD, Ferreira LS, Fillipo P, Silva DCB, Soldateli G, Ferraroni NR, Dantas E de O, Pestana S, Mansour E, Ulaf RG, Prando C, Condino Neto A, Grumach AS. Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: across-sectional study [Internet]. Journal of Clinical Immunology. 2021 ; 41( 7): 1479-1489.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s10875-021-01066-8
Vancouver
Goudouris ES, Mariz FP, Mendonça LO, Aranda CS, Guimarães RR, Kokron CM, Barros MAMT, Anísio F, Alonso MLO, Marcelino FC, Valle SOR, Dortas Junior SD, Barreto IDP, Ferreira JFS, Roxo Junior P, Silva AM do R, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Gesu RSWD, Ferreira LS, Fillipo P, Silva DCB, Soldateli G, Ferraroni NR, Dantas E de O, Pestana S, Mansour E, Ulaf RG, Prando C, Condino Neto A, Grumach AS. Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: across-sectional study [Internet]. Journal of Clinical Immunology. 2021 ; 41( 7): 1479-1489.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s10875-021-01066-8
Artigo de periodico
Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale (2021)
Seixas-Moizes, Julieta; Boerlage, Anneke; Lia, Érica Negrini; Santos, Lucas Emmanuel Lopes e; Zucoloto, Miriane Lucindo; Dach, Fabíola; Papassidero, Priscila Colavite; Wichert-Ana, Laís Almeida Leal; Della Pasqua, Oscar; Wiesebron, Marianne Louise; Icuma, Tatiana Reis; Lanchote, Vera Lucia; Coelho, Eduardo Barbosa; Tibboel, Dick; Wichert-Ana, Lauro
Source: Dementia and Geriatric Cognitive Disorders Extra. Unidades: FMRP, FCFRP
Subjects: DOR, IDOSOS, ESTUDOS DE VALIDAÇÃO, DEMÊNCIA, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEIXAS-MOIZES, Julieta et al. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale. Dementia and Geriatric Cognitive Disorders Extra, v. 11, n. 3, p. 314-323, 2021Tradução . . Disponível em: https://doi.org/10.1159/000520455. Acesso em: 05 nov. 2024.
APA
Seixas-Moizes, J., Boerlage, A., Lia, É. N., Santos, L. E. L. e, Zucoloto, M. L., Dach, F., et al. (2021). Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale. Dementia and Geriatric Cognitive Disorders Extra, 11( 3), 314-323. doi:10.1159/000520455
NLM
Seixas-Moizes J, Boerlage A, Lia ÉN, Santos LEL e, Zucoloto ML, Dach F, Papassidero PC, Wichert-Ana LAL, Della Pasqua O, Wiesebron ML, Icuma TR, Lanchote VL, Coelho EB, Tibboel D, Wichert-Ana L. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale [Internet]. Dementia and Geriatric Cognitive Disorders Extra. 2021 ; 11( 3): 314-323.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000520455
Vancouver
Seixas-Moizes J, Boerlage A, Lia ÉN, Santos LEL e, Zucoloto ML, Dach F, Papassidero PC, Wichert-Ana LAL, Della Pasqua O, Wiesebron ML, Icuma TR, Lanchote VL, Coelho EB, Tibboel D, Wichert-Ana L. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale [Internet]. Dementia and Geriatric Cognitive Disorders Extra. 2021 ; 11( 3): 314-323.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000520455
Artigo de periodico
Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the Multi-Center EU-GEI Study (2021)
Ajnakina, Olesya; Rodriguez, Victoria; Quattrone, Diego; Forti, Marta Di; Vassos, Evangelos; Arango, Celso; Berardi, Domenico; Bernardo, Miquel; Bobes, Julio; Haan, Lieuwe de; Del-Ben, Cristina Marta ; Gayer-Anderson, Charlotte; Jongsma, Hannah E.; Lasalvia, Antonio; Tosato, Sarah; Llorca, Pierre-Michel; Menezes, Paulo Rossi ; Rutten, Bart P.; Santos, José Luís dos; Sanjuan, Julio; Selten, Jean-Paul; Szoke, Andrei; Tarricone, Ilaria; D’Andrea, Giuseppe; Richards, Alexander; Tortelli, Andrea; Velthorst, Eva; Jones, Peter B.; Romero, Manuel Arrojo; Cascia, Caterina La; Kirkbride, James B.; van Os, Jim; O’Donovan, Mick; Murray, Robin M.; Loureiro, Camila Marcelino; Shuhama, Rosana
Source: Schizophrenia Bulletin. Unidades: FMRP, FM, EERP
Subjects: TRANSTORNOS PSICÓTICOS, ESTUDOS MULTICÊNTRICOS, INTERAÇÃO GENÓTIPO-AMBIENTE, ESQUIZOFRENIA, TRANSTORNO BIPOLAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AJNAKINA, Olesya et al. Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the Multi-Center EU-GEI Study. Schizophrenia Bulletin, v. 47, n. 6, p. 1653-1662, 2021Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbab055. Acesso em: 05 nov. 2024.
APA
Ajnakina, O., Rodriguez, V., Quattrone, D., Forti, M. D., Vassos, E., Arango, C., et al. (2021). Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the Multi-Center EU-GEI Study. Schizophrenia Bulletin, 47( 6), 1653-1662. doi:10.1093/schbul/sbab055
NLM
Ajnakina O, Rodriguez V, Quattrone D, Forti MD, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, Haan L de, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Lasalvia A, Tosato S, Llorca P-M, Menezes PR, Rutten BP, Santos JL dos, Sanjuan J, Selten J-P, Szoke A, Tarricone I, D’Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Romero MA, Cascia CL, Kirkbride JB, van Os J, O’Donovan M, Murray RM, Loureiro CM, Shuhama R. Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the Multi-Center EU-GEI Study [Internet]. Schizophrenia Bulletin. 2021 ; 47( 6): 1653-1662.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/schbul/sbab055
Vancouver
Ajnakina O, Rodriguez V, Quattrone D, Forti MD, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, Haan L de, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Lasalvia A, Tosato S, Llorca P-M, Menezes PR, Rutten BP, Santos JL dos, Sanjuan J, Selten J-P, Szoke A, Tarricone I, D’Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Romero MA, Cascia CL, Kirkbride JB, van Os J, O’Donovan M, Murray RM, Loureiro CM, Shuhama R. Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results from the Multi-Center EU-GEI Study [Internet]. Schizophrenia Bulletin. 2021 ; 47( 6): 1653-1662.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/schbul/sbab055
Trabalho de evento-resumo periodico
Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) (2021)
Bonifacio, L.; Ramacciotti, E.; Agati, L.; Vilar, F.; Tojal, A.; Souza, H.; Louzada Júnior, Paulo; Fonseca, Benedito Antonio Lopes da; Lopes, R.; Kallas, Esper Georges ; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, CITOCINAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 05 nov. 2024. , 2021
APA
Bonifacio, L., Ramacciotti, E., Agati, L., Vilar, F., Tojal, A., Souza, H., et al. (2021). Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Artigo de periodico
Influence of including patients with premorbid disability in acute stroke trials: the HeadPoST experience (2021)
Wang, Xia; Moullaali, Tom J.; Ouyang, Menglu; Billot, Laurent; Sandset, Else Charlotte; Song, Lili; Delcourt, Candice; Hackett, Maree L.; Watkins, Caroline L.; Robinson, Thompson G.; Yang, Jie; Lavados, Pablo M.; Brunser, Alejandro; Olavarría, Verónica V.; Muñoz-Venturelli, Paula; Arima, Hisatomi; Middleton, Sandy; Pontes Neto, Octávio Marques; Pandian, Jeyaraj D.; Rogers, Kris; Anderson, Craig S.
Source: Cerebrovascular Diseases. Unidade: FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, IDOSOS, ESTUDOS MULTICÊNTRICOS, SELEÇÃO DE PACIENTES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, RESULTADO DE TRATAMENTO, PESSOAS COM DEFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Xia et al. Influence of including patients with premorbid disability in acute stroke trials: the HeadPoST experience. Cerebrovascular Diseases, v. 50, n. 1, p. 78-87, 2021Tradução . . Disponível em: https://doi.org/10.1159/000512608. Acesso em: 05 nov. 2024.
APA
Wang, X., Moullaali, T. J., Ouyang, M., Billot, L., Sandset, E. C., Song, L., et al. (2021). Influence of including patients with premorbid disability in acute stroke trials: the HeadPoST experience. Cerebrovascular Diseases, 50( 1), 78-87. doi:10.1159/000512608
NLM
Wang X, Moullaali TJ, Ouyang M, Billot L, Sandset EC, Song L, Delcourt C, Hackett ML, Watkins CL, Robinson TG, Yang J, Lavados P M, Brunser A, Olavarría VV, Muñoz-Venturelli P, Arima H, Middleton S, Pontes Neto OM, Pandian J D, Rogers K, Anderson CS. Influence of including patients with premorbid disability in acute stroke trials: the HeadPoST experience [Internet]. Cerebrovascular Diseases. 2021 ; 50( 1): 78-87.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000512608
Vancouver
Wang X, Moullaali TJ, Ouyang M, Billot L, Sandset EC, Song L, Delcourt C, Hackett ML, Watkins CL, Robinson TG, Yang J, Lavados P M, Brunser A, Olavarría VV, Muñoz-Venturelli P, Arima H, Middleton S, Pontes Neto OM, Pandian J D, Rogers K, Anderson CS. Influence of including patients with premorbid disability in acute stroke trials: the HeadPoST experience [Internet]. Cerebrovascular Diseases. 2021 ; 50( 1): 78-87.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000512608
Artigo de periodico
Safety and effectiveness of the pipeline flex embolization device with shield technology for the treatment of intracranial aneurysms: midterm results from a multicenter study (2020)
Trivelato, Felipe Padovani; Wajnberg, Eduardo; Rezende, Marco Túlio Salles; Ulhôa, Alexandre Cordeiro; Piske, Ronie Leo; Abud, Thiago Giansante; Castro-Afonso, Luis Henrique de; Abath, Carlos Gustavo Coutinho; Nakiri, Guilherme Seizem; Araújo, João Francisco Santoro; Silva, José Laércio Júnior; Tosello, Renato Tavares; Vanzin, José Ricardo; Manzato, Luciano Bambini; Baccin, Carlos Eduardo; Mota, Bruno Anderson Araújo da; Abud, Daniel Giansante
Source: Neurosurgery. Unidade: FMRP
Subjects: ANEURISMA INTRACRANIANO, ESTUDOS MULTICÊNTRICOS, CONTENEDORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIVELATO, Felipe Padovani et al. Safety and effectiveness of the pipeline flex embolization device with shield technology for the treatment of intracranial aneurysms: midterm results from a multicenter study. Neurosurgery, v. 87, n. 1, p. 104-111, 2020Tradução . . Disponível em: https://doi.org/10.1093/neuros/nyz356. Acesso em: 05 nov. 2024.
APA
Trivelato, F. P., Wajnberg, E., Rezende, M. T. S., Ulhôa, A. C., Piske, R. L., Abud, T. G., et al. (2020). Safety and effectiveness of the pipeline flex embolization device with shield technology for the treatment of intracranial aneurysms: midterm results from a multicenter study. Neurosurgery, 87( 1), 104-111. doi:10.1093/neuros/nyz356
NLM
Trivelato FP, Wajnberg E, Rezende MTS, Ulhôa AC, Piske RL, Abud TG, Castro-Afonso LH de, Abath CGC, Nakiri GS, Araújo JFS, Silva JLJ, Tosello RT, Vanzin JR, Manzato LB, Baccin CE, Mota BAA da, Abud DG. Safety and effectiveness of the pipeline flex embolization device with shield technology for the treatment of intracranial aneurysms: midterm results from a multicenter study [Internet]. Neurosurgery. 2020 ; 87( 1): 104-111.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/neuros/nyz356
Vancouver
Trivelato FP, Wajnberg E, Rezende MTS, Ulhôa AC, Piske RL, Abud TG, Castro-Afonso LH de, Abath CGC, Nakiri GS, Araújo JFS, Silva JLJ, Tosello RT, Vanzin JR, Manzato LB, Baccin CE, Mota BAA da, Abud DG. Safety and effectiveness of the pipeline flex embolization device with shield technology for the treatment of intracranial aneurysms: midterm results from a multicenter study [Internet]. Neurosurgery. 2020 ; 87( 1): 104-111.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1093/neuros/nyz356
Artigo de periodico
Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study (2020)
Parra, Rogério Serafim ; Chebli, Julio; Chebli, Liliana; Bertges, Erika; Ambrogini Junior, Orlando; Schiavetti, Bianca; Alves Júnior, Antonio José; Flores, Cristina; Lubini, Marcio; Gasparetti Junior, Newton; Bafutto, Mauro; Azevedo, Matheus Freitas Cardoso de; Damiao, Aderson Omar Mourão Cintra; Queiroz, Natalia Sousa Freitas ; Steinwurz, Flavio; Carvalho, Nayara; Boratto, Sandra; Vilela, Eduardo; Rocha, José Joaquim Ribeiro da ; Féres, Omar
Source: The American Journal of Gastroenterology. Unidades: FMRP, FM
Subjects: DOENÇA DE CROHN, EFETIVIDADE, ESTUDOS MULTICÊNTRICOS, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study. The American Journal of Gastroenterology, v. 115, p. S2, 2020Tradução . . Disponível em: https://doi.org/10.14309/01.ajg.0000722828.45880.db. Acesso em: 05 nov. 2024.
APA
Parra, R. S., Chebli, J., Chebli, L., Bertges, E., Ambrogini Junior, O., Schiavetti, B., et al. (2020). Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study. The American Journal of Gastroenterology, 115, S2. doi:10.14309/01.ajg.0000722828.45880.db
NLM
Parra RS, Chebli J, Chebli L, Bertges E, Ambrogini Junior O, Schiavetti B, Alves Júnior AJ, Flores C, Lubini M, Gasparetti Junior N, Bafutto M, Azevedo MFC de, Damiao AOMC, Queiroz NSF, Steinwurz F, Carvalho N, Boratto S, Vilela E, Rocha JJR da, Féres O. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study [Internet]. The American Journal of Gastroenterology. 2020 ; 115 S2.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14309/01.ajg.0000722828.45880.db
Vancouver
Parra RS, Chebli J, Chebli L, Bertges E, Ambrogini Junior O, Schiavetti B, Alves Júnior AJ, Flores C, Lubini M, Gasparetti Junior N, Bafutto M, Azevedo MFC de, Damiao AOMC, Queiroz NSF, Steinwurz F, Carvalho N, Boratto S, Vilela E, Rocha JJR da, Féres O. Long-term effectiveness and safety of ustekinumab for the treatment of Crohn´s disease: a brazilian multicentre real-world study [Internet]. The American Journal of Gastroenterology. 2020 ; 115 S2.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14309/01.ajg.0000722828.45880.db
Artigo de periodico
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial (2020)
Biagioni, Rodrigo Bruno; Lopes, Renato Delascio; Agati, Leandro Barile; Sacilotto, Roberto; Wolosker, Nelson ; Sobreira, Marcone Lima; Soares, Bruno Leonardo de Freitas; Joviliano, Edwaldo Edner ; Bernardi, Walkiria Hueb; Castelli Junior, Valter; Caffaro, Roberto Augusto; Fioranelli, Alexandre; Bellen, Bonno Van; Casella, Ivan Benaduce; Fidelis, Ronald José Ribeiro; Flumignan, Ronald Luiz Gomes; Comerota, Anthony James; Ramacciotti, Eduardo
Source: American Heart Journal. Unidades: FM, FMRP
Subjects: ANGIOPLASTIA, ISQUEMIA, CIRURGIA, PERNA, ESTUDOS MULTICÊNTRICOS, ARTÉRIA POPLÍTEA, COMPLICAÇÕES PÓS-OPERATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIAGIONI, Rodrigo Bruno et al. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, v. 227, p. 100-106, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2020.06.010. Acesso em: 05 nov. 2024.
APA
Biagioni, R. B., Lopes, R. D., Agati, L. B., Sacilotto, R., Wolosker, N., Sobreira, M. L., et al. (2020). Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American Heart Journal, 227, 100-106. doi:10.1016/j.ahj.2020.06.010
NLM
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010
Vancouver
Biagioni RB, Lopes RD, Agati LB, Sacilotto R, Wolosker N, Sobreira ML, Soares BL de F, Joviliano EE, Bernardi WH, Castelli Junior V, Caffaro RA, Fioranelli A, Bellen BV, Casella IB, Fidelis RJR, Flumignan RLG, Comerota AJ, Ramacciotti E. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial [Internet]. American Heart Journal. 2020 ; 227 100-106.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ahj.2020.06.010
Artigo de periodico
Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms (2019)
Trivelato, Felipe Padovani; Abud, Daniel Giansante ; Ulhôa, Alexandre Cordeiro; Waihrich, Eduardo Siqueira; Abud, Thiago Giansante; Castro-Afonso, Luis Henrique de; Nakiri, Guilherme Seizem; Castro, Guilherme Duarte de; Parente, Bruno de Sousa Mendes; Silva, Rodrigo dos Santos; Manzato, Luciano Bambini; Bonadio, Lucas Eduardo; Viana, Dinark Conceição; Vanzin, José Ricardo; Baccin, Carlos Eduardo; Rezende, Marco Túlio Salles
Source: Stroke. Unidade: FMRP
Subjects: ANEURISMA, ANGIOGRAFIA, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIVELATO, Felipe Padovani et al. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke, v. 50, n. 9, p. 2351-2358, 2019Tradução . . Disponível em: https://doi.org/10.1161/STROKEAHA.119.025407. Acesso em: 05 nov. 2024.
APA
Trivelato, F. P., Abud, D. G., Ulhôa, A. C., Waihrich, E. S., Abud, T. G., Castro-Afonso, L. H. de, et al. (2019). Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke, 50( 9), 2351-2358. doi:10.1161/STROKEAHA.119.025407
NLM
Trivelato FP, Abud DG, Ulhôa AC, Waihrich ES, Abud TG, Castro-Afonso LH de, Nakiri GS, Castro GD de, Parente B de SM, Silva R dos S, Manzato LB, Bonadio LE, Viana DC, Vanzin JR, Baccin CE, Rezende MTS. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms [Internet]. Stroke. 2019 ; 50( 9): 2351-2358.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1161/STROKEAHA.119.025407
Vancouver
Trivelato FP, Abud DG, Ulhôa AC, Waihrich ES, Abud TG, Castro-Afonso LH de, Nakiri GS, Castro GD de, Parente B de SM, Silva R dos S, Manzato LB, Bonadio LE, Viana DC, Vanzin JR, Baccin CE, Rezende MTS. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms [Internet]. Stroke. 2019 ; 50( 9): 2351-2358.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1161/STROKEAHA.119.025407
Artigo de periodico
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study (2019)
Di Forti, Marta; Quattrone, Diego; Freeman, Tom P; Tripoli, Giada; Gayer-Anderson, Charlotte; Quigley, Harriet; Rodriguez, Victoria; Jongsma, Hannah E; Ferraro, Laura; Cascia, Caterina La; Del-Ben, Cristina Marta
Source: Lancet psychiatry. Unidades: FM, FMRP
Subjects: TRANSTORNOS PSICÓTICOS, INCIDÊNCIA, TABAGISMO, CANNABIS, SAÚDE PÚBLICA, ESTUDOS MULTICÊNTRICOS, EUROPA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DI FORTI, Marta et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet psychiatry, v. 6, n. 5, p. 427-436, 2019Tradução . . Disponível em: https://doi.org/10.1016/S2215-0366(19)30048-3. Acesso em: 05 nov. 2024.
APA
Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., et al. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet psychiatry, 6( 5), 427-436. doi:10.1016/S2215-0366(19)30048-3
NLM
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, Cascia CL, Del-Ben CM. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study [Internet]. Lancet psychiatry. 2019 ; 6( 5): 427-436.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/S2215-0366(19)30048-3
Vancouver
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, Cascia CL, Del-Ben CM. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study [Internet]. Lancet psychiatry. 2019 ; 6( 5): 427-436.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/S2215-0366(19)30048-3
Artigo de periodico
Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases (2018)
Clemente, Gleice; Silva, Clovis Artur Almeida da; Sacchetti, Silvana B.; Ferriani, Virgínia Paes Leme; Oliveira, Sheila K.; Sztajnbok, Flavio; Bica, Bianca E. R. G.; Cavalcanti, André; Robazzi, Teresa; Bandeira, Marcia; Terreri, Maria Teresa
Source: Rheumatology International. Unidades: FM, FMRP
Subjects: ESTUDOS MULTICÊNTRICOS, CRIANÇAS, ARTERITE DE TAKAYASU, DIAGNÓSTICO TARDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CLEMENTE, Gleice et al. Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases. Rheumatology International, v. 38, n. 6, p. 1089-1094, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-4030-4. Acesso em: 05 nov. 2024.
APA
Clemente, G., Silva, C. A. A. da, Sacchetti, S. B., Ferriani, V. P. L., Oliveira, S. K., Sztajnbok, F., et al. (2018). Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases. Rheumatology International, 38( 6), 1089-1094. doi:10.1007/s00296-018-4030-4
NLM
Clemente G, Silva CAA da, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT. Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases [Internet]. Rheumatology International. 2018 ; 38( 6): 1089-1094.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00296-018-4030-4
Vancouver
Clemente G, Silva CAA da, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT. Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases [Internet]. Rheumatology International. 2018 ; 38( 6): 1089-1094.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00296-018-4030-4
Artigo de periodico
Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus (2017)
Novak, Glaucia V.; Marques, Mariana; Balbi, Verena; Gormezano, Natali W. S.; Kozu, Kátia; Sakamoto, Ana P.; Pereira, Rosa M. R.; Terreri, Maria T.; Magalhães, Claudia S.; Guariento, Andressa; Sallum, Adriana M. E.; Marini, Roberto; Ferriani, Virginia Paes Leme; Barbosa, Cássia Maria; Castro, Tânia Caroline Monteiro de; Ramos, Valéria C.; Bonfá, Eloisa; Silva, Clovis A.
Source: Autoimmunity Reviews. Unidades: FM, FMRP
Subjects: CRIANÇAS, ESTUDOS MULTICÊNTRICOS, ESTUDOS DE COORTES, AUTOANTICORPOS, LÚPUS ERITEMATOSO SISTÊMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVAK, Glaucia V. et al. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus. Autoimmunity Reviews, v. 16, n. 2, p. 132-135, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.autrev.2016.12.004. Acesso em: 05 nov. 2024.
APA
Novak, G. V., Marques, M., Balbi, V., Gormezano, N. W. S., Kozu, K., Sakamoto, A. P., et al. (2017). Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus. Autoimmunity Reviews, 16( 2), 132-135. doi:10.1016/j.autrev.2016.12.004
NLM
Novak GV, Marques M, Balbi V, Gormezano NWS, Kozu K, Sakamoto AP, Pereira RMR, Terreri MT, Magalhães CS, Guariento A, Sallum AME, Marini R, Ferriani VPL, Barbosa CM, Castro TCM de, Ramos VC, Bonfá E, Silva CA. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus [Internet]. Autoimmunity Reviews. 2017 ; 16( 2): 132-135.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.autrev.2016.12.004
Vancouver
Novak GV, Marques M, Balbi V, Gormezano NWS, Kozu K, Sakamoto AP, Pereira RMR, Terreri MT, Magalhães CS, Guariento A, Sallum AME, Marini R, Ferriani VPL, Barbosa CM, Castro TCM de, Ramos VC, Bonfá E, Silva CA. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus [Internet]. Autoimmunity Reviews. 2017 ; 16( 2): 132-135.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.autrev.2016.12.004
Trabalho de evento-resumo periodico
Artrite reumatoide no Brasil: estudo real - uma coorte prospectiva nacionalmente representativa (2017)
Pinheiro, Geraldo da Rocha Castelar; Vargas-Santos, Ana Beatriz; Albuquerque, C.; Amorim, Rodrigo Balbino Chaves; Giorgi, R. D.; Radominski, Sebastião Cezar; Pereira, I. A.; Guimarães, M. F. R.; Bertolo, M.; Louzada Júnior, Paulo; Lobato, M. F.; Bonfiglioli, K.; Brenol, Claiton Viegas; Mota, L. M. H.
Source: Revista Brasileira de Reumatologia. Conference titles: Congresso Brasileiro de Reumatologia. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE, ESTUDOS DE COORTES, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Geraldo da Rocha Castelar et al. Artrite reumatoide no Brasil: estudo real - uma coorte prospectiva nacionalmente representativa. Revista Brasileira de Reumatologia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.rbr.2017.07.534. Acesso em: 05 nov. 2024. , 2017
APA
Pinheiro, G. da R. C., Vargas-Santos, A. B., Albuquerque, C., Amorim, R. B. C., Giorgi, R. D., Radominski, S. C., et al. (2017). Artrite reumatoide no Brasil: estudo real - uma coorte prospectiva nacionalmente representativa. Revista Brasileira de Reumatologia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.rbr.2017.07.534
NLM
Pinheiro G da RC, Vargas-Santos AB, Albuquerque C, Amorim RBC, Giorgi RD, Radominski SC, Pereira IA, Guimarães MFR, Bertolo M, Louzada Júnior P, Lobato MF, Bonfiglioli K, Brenol CV, Mota LMH. Artrite reumatoide no Brasil: estudo real - uma coorte prospectiva nacionalmente representativa [Internet]. Revista Brasileira de Reumatologia. 2017 ; 57 S379.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.rbr.2017.07.534
Vancouver
Pinheiro G da RC, Vargas-Santos AB, Albuquerque C, Amorim RBC, Giorgi RD, Radominski SC, Pereira IA, Guimarães MFR, Bertolo M, Louzada Júnior P, Lobato MF, Bonfiglioli K, Brenol CV, Mota LMH. Artrite reumatoide no Brasil: estudo real - uma coorte prospectiva nacionalmente representativa [Internet]. Revista Brasileira de Reumatologia. 2017 ; 57 S379.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.rbr.2017.07.534
Artigo de periodico
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study (2017)
Callefi, Luciana Azevêdo; Villela-Nogueira, Cristiane Alves; Tenore, Simone de Barros; Carnaúba-Júnior, Dimas; Coelho, Henrique Sérgio Moraes; Pinto, Paulo de Tarso A.; Nabuco, Letícia Cancella; Pessôa, Mário Guimarães; Ferraz, Maria Lúcia Cardoso Gomes; Ferreira, Paulo Roberto Abrão; Martinelli, Ana de Lourdes Candolo; Chachá, Silvana Gama Florencio; Ferreira, Adalgisa de Souza Paiva; Bisio, Alessandra Porto de Macedo; Brandão-Mello, Carlos Eduardo; Álvares-da-Silva, Mário Reis; Reuter, Tania; Ivantes, Claudia Alexandra Pontes; Perez, Renata de Mello; Mendes-Côrrea, Maria Cássia Jacintho
Source: Clinics. Unidade: FMRP
Subjects: INIBIDORES DE ENZIMAS, HEPATITE C, DOENÇA CRÔNICA, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALLEFI, Luciana Azevêdo et al. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, v. 72, n. 6, p. 378-385, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(06)08. Acesso em: 05 nov. 2024.
APA
Callefi, L. A., Villela-Nogueira, C. A., Tenore, S. de B., Carnaúba-Júnior, D., Coelho, H. S. M., Pinto, P. de T. A., et al. (2017). Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, 72( 6), 378-385. doi:10.6061/clinics/2017(06)08
NLM
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2017(06)08
Vancouver
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2024 nov. 05 ] Available from: https://doi.org/10.6061/clinics/2017(06)08

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration